A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies
Clinical trial NCT02013804 · COMPLETED
Trial details
- NCT number
- NCT02013804
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-19
- Primary completion
- 2017-05-18
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.